Amy Quinlan - Aug 1, 2024 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Vice President of Finance
Signature
/s/ Katie Kazem, Attorney-in-Fact
Stock symbol
VOR
Transactions as of
Aug 1, 2024
Transactions value $
-$4,155
Form type
4
Date filed
9/4/2024, 04:15 PM
Previous filing
Jun 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Tax liability -$322 -343 -0.61% $0.94 55.5K Aug 1, 2024 Direct F1
transaction VOR Common Stock Tax liability -$179 -206 -0.37% $0.87 55.3K Aug 6, 2024 Direct F1
transaction VOR Common Stock Tax liability -$3.65K -4.4K -7.97% $0.83 50.9K Sep 3, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.